文献速递创伤与烧伤复苏、休克与脓毒症

初始院内低呼气末二氧化碳预测创伤患者不良结局,是创伤抢救室的有用辅助指标

Low initial in-hospital end-tidal carbon dioxide predicts poor patient outcomes and is a useful trauma bay adjunct.
PubMed 文献 · Am J Emerg Med · 2022-03-23
一句话结论创伤抢救室初始呼气末二氧化碳≤29.5 mmHg与输血、死亡、不良去向和并发症风险升高独立相关,对早期输血的预测优于休克指数。

本研究在一级创伤中心前瞻性纳入2019至2020年成人创伤激活患者,在初始评估时用侧流式二氧化碳描记法测量创伤抢救室呼气末二氧化碳(ETCO2),以Liu法确定切点29.5 mmHg,将患者分为低ETCO2(≤29.5 mmHg)与正常ETCO2(>29.5 mmHg)。共955例完成初始院内ETCO2测量,入院患者493例中48.9%为低ETCO2。多因素回归校正后,低ETCO2与输血(OR 4.65,95%CI 2.0-10.7)、死亡(OR 5.10,95%CI 1.1-24.9)、不良去向(OR 1.64,95%CI 1.1-2.6)和并发症(OR 3.35,95%CI 1.5-7.4)风险升高相关。ETCO2对早期输血的预测优于休克指数(ROC曲线下面积67.6% vs 58.2%)。作者认为低ETCO2值可能对输血需求更具预测性,需进一步研究评估ETCO2作为早期创伤管理决策工具的作用。

要点

  • 创伤抢救室初始ETCO2≤29.5 mmHg与校正后输血风险升高相关(OR 4.65,95%CI 2.0-10.7)。
  • 低ETCO2与校正后死亡风险升高相关(OR 5.10,95%CI 1.1-24.9),与不良去向(OR 1.64,95%CI 1.1-2.6)和并发症(OR 3.35,95%CI 1.5-7.4)相关。
  • ETCO2对早期输血的预测优于休克指数(ROC曲线下面积67.6% vs 58.2%)。
  • 入院患者中48.9%存在低ETCO2,从到院至ETCO2测量中位时间4 min。
  • 低ETCO2患者年龄更大(中位53岁 vs 46岁,p=0.01),最高级别创伤激活比例更高(27.4% vs 19.8%,p=0.048),两组颅脑损伤无差异。

适用人群与场景

  • 2019至2020年就诊于一级创伤中心的成人创伤激活患者,所有创伤激活在初始评估时前瞻性测量创伤抢救室ETCO2。

诊断标准与关键阈值

  • 采用Liu法确定切点:ETCO2≤29.5 mmHg为低ETCO2,>29.5 mmHg为正常ETCO2,ETCO2由侧流式二氧化碳描记法测量。

研究设计与关键结果

  • 研究类型为前瞻性研究,共955例患者完成初始院内ETCO2测量,从到院至ETCO2测量中位时间4 min。
  • 入院患者493例中48.9%为低ETCO2;与正常ETCO2患者相比,低ETCO2患者年龄更大(中位53岁 vs 46岁,p=0.01),最高级别创伤激活比例更高(27.4% vs 19.8%,p=0.048),颅脑损伤无差异。
  • 校正后低ETCO2与输血(OR 4.65,95%CI 2.0-10.7)、死亡(OR 5.10,95%CI 1.1-24.9)、不良去向(OR 1.64,95%CI 1.1-2.6)和并发症(OR 3.35,95%CI 1.5-7.4)风险升高相关。
  • ETCO2对早期输血的预测优于休克指数(ROC曲线下面积67.6% vs 58.2%)。

证据类型、等级与局限

  • 证据类型:前瞻性研究,在一级创伤中心进行。
  • 局限:需进一步研究评估ETCO2作为早期创伤管理决策工具的作用(原文结论)。

对床旁实践的改变

  • 作者认为,与其他分诊工具相比,低ETCO2值可能对输血需求更具预测性。
  • 作者认为,需进一步研究评估ETCO2作为早期创伤管理决策工具的作用。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Appropriate triage of the trauma patient is critical. Low end-tidal carbon dioxide (ETCO2) is associated with mortality and hemorrhagic shock in trauma, but the relationship between low ETCO2 and important clinical variables is not known. This study investigates the association of initial in-hospital ETCO2 and patient outcomes, as well as the utility of ETCO2 as a predictive aid for blood transfusion.

METHODS: Adult patients who presented to a Level One trauma center from 2019 to 2020 were eligible. Trauma bay ETCO2 measured by side-stream capnography was prospectively obtained for all trauma activations at time of initial evaluation. Using the Liu method of cut point estimation, patients were stratified as having low (≤29.5 mmHg) or normal ETCO2 (>29.5 mmHg). Multivariable regression was used to estimate the association of low ETCO2 with patient outcomes.

RESULTS: A total of 955 patients underwent initial in-hospital ETCO2 measurement. Median time from arrival to ETCO2 measurement was 4 min. Among admitted patients (N = 493), 48.9% had low ETCO2. Compared to patients with normal ETCO2, those with low ETCO2 were older (median age 53 vs 46, p = 0.01) and more likely to have the highest trauma activation (27.4% vs 19.8%, p = 0.048). There was no difference in head injury. After adjustment, patients with low ETCO2 had greater odds of blood transfusion (OR 4.65, 95%CI 2.0-10.7), mortality (OR 5.10, 95%CI 1.1-24.9), inferior disposition (OR 1.64, 95%CI 1.1-2.6), and complications (OR 3.35, 95%CI 1.5-7.4). ETCO2 was more predictive of early blood transfusion than Shock Index (area under ROC = 67.6% vs 58.2%).

CONCLUSIONS: Low trauma bay ETCO2 remains significantly associated with inferior clinical outcomes after adjustment. In comparison to other triage tools, low ETCO2 values may be more predictive of the need for blood transfusion. Further studies are needed to evaluate the role of ETCO2 as a decision making tool for early trauma management.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Portelli Tremont JN, Caldas RA, Cook N, et al. Low initial in-hospital end-tidal carbon dioxide predicts poor patient outcomes and is a useful trauma bay adjunct. Am J Emerg Med. 2022. PMID: 35364477. doi:10.1016/j.ajem.2022.03.034

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。